Hearing impairment after subarachnoid hemorrhage.

Nicci Campbell, Carl Verschuur, Sophie Mitchell, Orlaith McCaffrey, Lewis Deane, Hannah Taylor, Rory Smith, Lesley Foulkes, James Glazier, Angela Darekar, Mark E Haacke, Diederik Bulters, Ian Galea

Journal: Annals of clinical and translational neurology 2020;6(3):420-430

PMID: 30911566

Abstract

BACKGROUND

Subarachnoid hemorrhage (SAH) survivors experience significant neurological disability, some of which is under-recognized by neurovascular clinical teams. We set out to objectively determine the occurrence of hearing impairment after SAH, characterize its peripheral and/or central origin, and investigate likely pathological correlates.

METHODS

In a case-control study ( = 41), participants were asked about new onset hearing difficulty 3 months post-SAH, compared with pre-SAH. Formal audiological assessment included otoscopy, pure tone audiometry, a questionnaire identifying symptoms of peripheral hearing loss and/or auditory processing disorder, and a test of speech understanding in noise. A separate cohort ( = 21) underwent quantitative susceptibility mapping (QSM) of the auditory cortex 6 months after SAH, for correlation with hearing difficulty.

RESULTS

Twenty three percent of SAH patients reported hearing difficulty that was new in onset post-SAH. SAH patients had poorer pure tone thresholds compared to controls. The proportion of patients with peripheral hearing loss as defined by the World Health Organization and British Audiological Society was however not increased, compared to controls. All SAH patients experienced symptoms of auditory processing disorder post-SAH, with speech-in-noise test scores significantly worse versus controls. Iron deposition in the auditory cortex was higher in patients reporting hearing difficulty versus those who did not.

CONCLUSION

This study firmly establishes hearing impairment as a frequent clinical feature after SAH. It primarily consists of an auditory processing disorder, mechanistically linked to iron deposition in the auditory cortex. Neurovascular teams should inquire about hearing, and refer SAH patients for audiological assessment and management.

Address: Auditory Implant Service Faculty of Engineering and the Environment University of Southampton Southampton United Kingdom.; Clinical Neurosciences Clinical and Experimental Sciences Faculty of Medicine University of Southampton Southampton United Kingdom.; Wessex Neurological Centre University Hospital Southampton NHS Foundation Trust University of Southampton Southampton United Kingdom.; Medical Physics University Hospital Southampton NHS Foundation Trust Southampton United Kingdom.; Department of Radiology Wayne State University Detroit Michigan.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.